OrganiGram Holdings Inc represents a commitment to excellence, sustainability, and innovation in the cannabis industry. With a focus on producing high-quality, organic cannabis products, OrganiGram prioritizes the well-being of its customers and the environment. The company's corporate philosophy is centered around providing safe and reliable cannabis options, while also valuing social responsibility and community engagement. OrganiGram is dedicated to cultivating relationships with its customers, understanding their needs, and consistently delivering superior products. By upholding these core values, OrganiGram Holdings Inc strives to be a trusted leader in the cannabis market.

OrganiGram Holdings Inc is primarily present in Canada.

OrganiGram Holdings Inc has achieved several significant milestones in its operations. Firstly, the company expanded its production capacity through the completion of Phase 3 expansion in 2019. This expansion enabled OrganiGram to increase its annual cannabis production capacity to 76,000 kilograms. Additionally, OrganiGram has successfully developed innovative cannabis derivative products, such as cannabis-infused chocolates and powdered beverages. Moreover, the company has received various certifications, including organic certification by Pro-Cert, which further demonstrates its commitment to producing high-quality and sustainable cannabis products. By focusing on expansion, innovation, and quality, OrganiGram Holdings Inc has established itself as a leading player in the cannabis industry.

OrganiGram Holdings Inc is a Canadian cannabis company that was founded in 2013. It is a licensed producer of medical marijuana, with cultivation facilities located in Moncton, New Brunswick. The company's mission is to provide high-quality, organically-grown cannabis products to both medical and adult-use recreational consumers. OrganiGram Holdings Inc has a strong focus on innovation and sustainability, employing advanced growing techniques and operating under strict quality control measures. With a diverse product line and a commitment to customer satisfaction, OrganiGram Holdings Inc has established itself as a leading player in the cannabis industry.

The main competitors of OrganiGram Holdings Inc in the market include companies such as Canopy Growth Corporation and Aurora Cannabis Inc.

OrganiGram Holdings Inc is primarily active in the cannabis industry.

The business model of OrganiGram Holdings Inc is focused on the cultivation, production, and distribution of high-quality cannabis products. As a leading Canadian licensed producer, OrganiGram operates state-of-the-art indoor facilities to ensure consistent, premium cannabis cultivation. The company's business model revolves around their commitment to innovation, sustainability, and customer satisfaction. By leveraging advanced growing techniques, strategic partnerships, and a diverse product portfolio, OrganiGram aims to cater to both medical and adult-use recreational cannabis markets. With a customer-centric approach and ongoing research and development, OrganiGram Holdings Inc strives to deliver safe, reliable, and exceptional cannabis experiences while contributing to the overall growth of the industry.

Rasio P/E OrganiGram Holdings adalah -4,18.

Rasio KUV dari OrganiGram Holdings adalah 1,20.

Skor Kualitas AlleAktien untuk OrganiGram Holdings adalah 5/10.

Omset diharapkan OrganiGram Holdings adalah 162,28 Juta. CAD.

Laba diharapkan OrganiGram Holdings adalah -46,52 Juta. CAD.

OrganiGram Holdings Inc. is a Canadian company specializing in the production, distribution, and marketing of medical cannabis. The business model of OrganiGram includes a wide range of products that can be used for a variety of medical conditions and symptoms. OrganiGram's main focus is the production of cannabis flowers rich in cannabinoids such as THC and CBD. These flowers are offered in different formats, including dried, pressed buds and cured flowers that can be used in capsules or vaporizers. OrganiGram also offers various strains of cannabis flowers specifically developed for different medical conditions or symptoms. In addition to cannabis flowers, OrganiGram also produces various other cannabis products, such as oils and extracts. These products are made from the flowers of the cannabis plant and provide a convenient way to harness the health benefits of cannabis without actually having to smoke or vaporize it. OrganiGram also offers vaporizable oils specifically developed for medical purposes. Another product segment of OrganiGram includes edible products made from cannabis. These include chocolates, candies, and beverages, all of which contain a controlled amount of cannabinoids and are specially developed for medical purposes. OrganiGram also offers a variety of accessories and other products specifically designed for the use of medical cannabis, including vaporizers, capsules, rolling papers, and other utensils suitable for use with OrganiGram's cannabis products. To produce and distribute these products, OrganiGram has developed a comprehensive cultivation system that ensures the flowers and plants are of the highest quality. The company utilizes state-of-the-art technology and methods to ensure the purity, efficacy, and quality of its products. In addition, OrganiGram operates a wide range of online and retail activities to market and sell its products. The company uses a variety of traditional and digital marketing channels to raise awareness of its brand and promote awareness of the health benefits of medical cannabis. Overall, OrganiGram's business model is very diverse and includes a variety of products and services specifically tailored to the use of medical cannabis. Through its innovative research and development, advanced cultivation system, and comprehensive marketing strategy, OrganiGram is able to serve a growing customer base seeking safe and effective products for symptom relief and disease management.

OrganiGram Holdings membayarkan dividen sebesar 0 CAD yang dibagi melalui pembayaran dalam setahun.

Dividen untuk OrganiGram Holdings saat ini tidak dapat dihitung atau perusahaan tidak membagikan dividen.

ISIN dari OrganiGram Holdings adalah CA68620P1018.

Ticker dari OrganiGram Holdings adalah OGI.TO.

Dalam 12 bulan terakhir, OrganiGram Holdings membayar dividen sebesar . Ini setara dengan yield dividen sekitar . Untuk 12 bulan mendatang, OrganiGram Holdings diperkirakan akan membayar dividen sebesar 0 CAD.

Imbal hasil dividen dari OrganiGram Holdings saat ini adalah .

OrganiGram Holdings membayar dividen setiap kuartal. Dividen ini dibayarkan pada bulan .

OrganiGram Holdings membayar dividen setiap tahun dalam 0 tahun terakhir.

Untuk 12 bulan ke depan, diperkirakan akan ada dividen sebesar 0 CAD. Ini setara dengan yield dividen sebesar 0 %.

OrganiGram Holdings dikelompokkan dalam sektor 'Kesehatan'.

Untuk menerima dividen terakhir dari OrganiGram Holdings tanggal 22/9/2024 sejumlah 0 CAD, Anda harus memiliki saham tersebut di portofolio sebelum tanggal Ex-Tag pada 22/9/2024.

Pembayaran dividen terakhir dilakukan pada 22/9/2024.

Pada tahun 2023, OrganiGram Holdings 0 CAD telah dibayarkan sebagai dividen.

Dividen dari OrganiGram Holdings dibayarkan dalam CAD.